ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Multi-Level Confinement Single-Molecule Charge Transfer Activated PRET for Near-Infrared Targeted Cell Imaging.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Supramolecular Allostery Achieves Tunable Luminescence Aromatic Bridged Phenothiazine Noncovalent Frameworks.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Cucurbit[8]Uril Achieved Single-Molecule Chiral Transfer to Supramolecular Circularly Polarized Luminescence.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This work reports an interesting phosphorescent resonance energy transfer (PRET) system with a large Stokes shift (320 nm) and near-infrared (NIR) delayed fluorescence emission for high-performance bioimaging, where a tailored charge transfer supramolecular assembly was constructed from dibenzyl-bridged pyridinium derivative (G1), cucurbit[8]uril (CB[8]), and β-cyclodextrin-grafted hyaluronic acid (HACD). The rigid dibenzyl linker of G1 induces a unique zigzag conformation, enabling G1 to form an antiparallel charge transfer complex with CB[8], giving a binding constant as high as 5.49 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.